Nada Alsuhebany, Hamad Alkhalaf, Faisal Alshehri, Abdullah Alkhulaifi, Mohammed Almoteb, Abdullah Alshammari, Mohammed Alnuhait, Lama Alfehaid, Abdullah M. Alrajhi, Mohammed Alzahrani, Maha AlDoughaim. "Validation of the HFA-ICOS cardiovascular toxicity risk tool in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors: Real-world data from the Saudi population.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e24009